11 research outputs found

    Time-change profile of plasma liraglutide concentration following subcutaneous administration of liraglutide in diabetic patients with ESRD on the days of on-hemodialysis and off-hemodialysis.

    No full text
    <p>n = 10.</p><p>Time-change profile of plasma liraglutide concentration following subcutaneous administration of liraglutide in diabetic patients with ESRD on the days of on-hemodialysis and off-hemodialysis.</p

    Baseline demographics and characteristics of the patients.

    No full text
    <p>*Values are mean ± SD (n = 10).</p><p>**0.9 mg (8 males and 1 female), 0.6 mg (1 male).</p><p>***1 patient had previously been treated with insulin only, and had switched to liraglutide 3 months prior to initiation of the study.</p><p>AST: Aspartate aminotransferase (SGOT).</p><p>ALT: Alanine aminotransferase (SGPT).</p><p>BUN: Blood urea nitrogen.</p><p>CPK: Creatinine phosphokinase.</p><p>Baseline demographics and characteristics of the patients.</p

    Pharmacokinetic parameters of liraglutide following subcutaneous administration of liraglutide to diabetic patients with ESRD on the day of on-hemodialysis and off-hemodialysis.

    No full text
    <p>-: not calculated, n = 10.</p><p>Pharmacokinetic parameters of liraglutide following subcutaneous administration of liraglutide to diabetic patients with ESRD on the day of on-hemodialysis and off-hemodialysis.</p

    Plasma glucose profiles after subcutaneous administration of liraglutide in diabetic patients with ESRD on-hemodialysis and off-hemodialysis.

    No full text
    <p>Mean ± SD, n = 10.</p><p>*The analysis of 95% CI (log [CI]) could not be performed because zero values were included.</p><p>**p<0.05.</p><p>Plasma glucose profiles after subcutaneous administration of liraglutide in diabetic patients with ESRD on-hemodialysis and off-hemodialysis.</p
    corecore